BRIEF published on 11/20/2024 at 14:05, 1 year ago Mailbird Launches Mac Version of Its Popular Email Client Mailbird Mac Launch Email Client Expansion Cross-platform App Productivity Features User Integration Tools
BRIEF published on 11/20/2024 at 14:05, 1 year ago Mailbird lance la version Mac de son célèbre client de messagerie Lancement De Mailbird Sur Mac Extension Du Client De Messagerie Application Multiplateforme Fonctionnalités De Productivité Outils D'intégration Des Utilisateurs
PRESS RELEASE published on 11/20/2024 at 14:00, 1 year ago Mailbird Expands to Mac: Popular Windows Email Client Launches Much-Anticipated Mac App Mailbird, the popular email client for Windows, launches Mac app, offering a clutter-free design and productivity features. Users can create a unified email experience with integrations Integrations Productivity Features Mailbird Email Client Mac App
Published on 12/05/2025 at 02:35, 4 hours 45 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 20 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 15 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 20 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 20 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 49 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 29 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 54 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 5 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 5 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 20 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 20 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 35 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 35 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
